Genomics Cos Tighten Belts as Capital Markets Dry Up, Experts Say | GenomeWeb

NEW YORK, March 22 - Applied Biosystems’ remarks regarding an expected slowdown in their short-term revenues indicates that smaller biotech and genomics companies have decided to limit big expenditures on new equipment while they ride out the economic downturn, company executives and analysts said Thursday. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.